Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's disease. [PDF]
Franch-Marti C +11 more
europepmc +1 more source
Surface-Engineered Precision Nano-Systems for Targeted Treatment of Huntington's Disease: A Review of Recent Advancements. [PDF]
Zhang J, Nie L, Ma J, Wang X.
europepmc +1 more source
Living with Risk, Aging with Uncertainty: A Narrative Review of Health and Genetic Vulnerability in Huntington's Disease. [PDF]
Muñoz-Ortega AV +2 more
europepmc +1 more source
Eye manifestations in Huntington's disease: an update on the potential of ocular biomarkers. [PDF]
Woods WA, Barker RA.
europepmc +1 more source
Pediatric-onset spinocerebellar ataxia type 3 with dual <i>ATXN3</i> and <i>HTT</i> gene mutations: a case report and literature-informed hypothesis. [PDF]
Wang D +7 more
europepmc +1 more source
Current Pharmacological Management in Juvenile Huntington's Disease.
Robertson L +7 more
europepmc +1 more source
Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice. [PDF]
Olmedo-Saura G +6 more
europepmc +1 more source
Late-Onset Huntington's Disease in Mexico: A Retrospective Study. [PDF]
Ochoa-Morales A +7 more
europepmc +1 more source
Pain processing and pain assessment in Huntington's disease: Study protocol of the Huntington's disease - PAIN study. [PDF]
Sprenger GP +4 more
europepmc +1 more source
Presentation Modes, Anticipation, and Penetrance: A Case Series of Huntington's Disease. [PDF]
Sumaiya T, Sultana R, Mridul MH.
europepmc +1 more source

